Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Accumulated Expenses (2016 - 2025)

Dentsply Sirona's Accumulated Expenses history spans 17 years, with the latest figure at $700.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses fell 7.16% year-over-year to $700.0 million, compared with a TTM value of $700.0 million through Dec 2025, down 7.16%, and an annual FY2025 reading of $700.0 million, down 7.16% over the prior year.
  • Accumulated Expenses for Q4 2025 was $700.0 million at Dentsply Sirona, down from $712.0 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $798.0 million in Q3 2024, with the low at $557.0 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $707.2 million, with a median of $718.5 million recorded in 2021.
  • Year-over-year, Accumulated Expenses soared 1753.66% in 2021 and then decreased 10.78% in 2025.
  • Tracing XRAY's Accumulated Expenses over 5 years: stood at $760.0 million in 2021, then fell by 4.34% to $727.0 million in 2022, then rose by 3.03% to $749.0 million in 2023, then increased by 0.67% to $754.0 million in 2024, then fell by 7.16% to $700.0 million in 2025.
  • Per Business Quant, the three most recent readings for XRAY's Accumulated Expenses are $700.0 million (Q4 2025), $712.0 million (Q3 2025), and $672.0 million (Q2 2025).